These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15210905)

  • 1. Do gender and race impact the use of antithrombotic therapy in patients with stroke/TIA?
    Lisabeth LD; Roychoudhury C; Brown DL; Levine SR
    Neurology; 2004 Jun; 62(12):2313-5. PubMed ID: 15210905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicines taken by older Australians after transient ischaemic attack or ischaemic stroke: a retrospective database study.
    Sluggett JK; Caughey GE; Ward MB; Gilbert AL
    Int J Clin Pharm; 2015 Oct; 37(5):782-9. PubMed ID: 25920907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity.
    Johnston SC; Fung LH; Gillum LA; Smith WS; Brass LM; Lichtman JH; Brown AN
    Stroke; 2001 May; 32(5):1061-8. PubMed ID: 11340210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
    Overgaard K; Poulsen TS; Husted SE
    Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary-prevention drug prescription in the very elderly after ischemic stroke or TIA.
    Ovbiagele B; Hills NK; Saver JL; Johnston SC
    Neurology; 2006 Feb; 66(3):313-8. PubMed ID: 16476928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy use at discharge and 1 year in patients with atrial fibrillation and acute stroke: results from the AVAIL Registry.
    Lopes RD; Shah BR; Olson DM; Zhao X; Pan W; Bushnell CD; Peterson ED
    Stroke; 2011 Dec; 42(12):3477-83. PubMed ID: 21903948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
    Chest; 2008 Jun; 133(6 Suppl):630S-669S. PubMed ID: 18574275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial differences in the medical treatment of elderly Medicare patients with acute myocardial infarction.
    Allison JJ; Kiefe CI; Centor RM; Box JB; Farmer RM
    J Gen Intern Med; 1996 Dec; 11(12):736-43. PubMed ID: 9016420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack.
    Scalia L; Calderone D; Capodanno D
    Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1027-1038. PubMed ID: 36031827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel.
    Burton TM; Lacey M; Liu F; Yu Y; Monsalvo ML; Lang K; Sander S
    J Med Econ; 2012; 15(6):1217-25. PubMed ID: 22857539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: a meta-analysis of randomized controlled trials.
    Li X; Zhou G; Zhou X; Zhou S
    J Neurol Sci; 2013 Sep; 332(1-2):92-6. PubMed ID: 23871093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of race and sex with the underuse of stroke prevention measures.
    Tuhrim S; Cooperman A; Rojas M; Brust JC; Koppel B; Martin K; Chassin M
    J Stroke Cerebrovasc Dis; 2008; 17(4):226-34. PubMed ID: 18589344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events.
    Hankey GJ; Eikelboom JW
    Lancet Neurol; 2010 Mar; 9(3):273-84. PubMed ID: 20170841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
    Hills NK; Johnston SC
    Stroke; 2008 Apr; 39(4):1228-32. PubMed ID: 18323509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombotic and anticoagulation therapy after stroke and transient ischemic attacks].
    Weber R; Frank B; Diener HC
    Nervenarzt; 2010 Dec; 81(12):1509-17; quiz 1518-9. PubMed ID: 21181335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy in transient ischemic attack patients.
    Held VE; Wolf ME; Hennerici MG
    Front Neurol Neurosci; 2014; 33():147-61. PubMed ID: 24157563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency department evaluation of ischemic stroke and TIA: the BASIC Project.
    Brown DL; Lisabeth LD; Garcia NM; Smith MA; Morgenstern LB
    Neurology; 2004 Dec; 63(12):2250-4. PubMed ID: 15623682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic and thrombolytic therapy for ischemic stroke.
    Fisher M
    J Thromb Thrombolysis; 1999 Apr; 7(2):165-9. PubMed ID: 10364768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic use following transient ischaemic attack or ischaemic stroke among older Australians with atrial fibrillation.
    Sluggett JK; Caughey GE; Ward MB; Gilbert AL
    Intern Med J; 2014 Nov; 44(11):1134-7. PubMed ID: 25367727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of race on cardiac care and outcomes in veterans with acute myocardial infarction.
    Petersen LA; Wright SM; Peterson ED; Daley J
    Med Care; 2002 Jan; 40(1 Suppl):I86-96. PubMed ID: 11789635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.